{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:46:43Z","timestamp":1764740803150,"version":"3.46.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.mrfmmm.2005.12.011","type":"journal-article","created":{"date-parts":[[2006,2,8]],"date-time":"2006-02-08T13:24:53Z","timestamp":1139405093000},"page":"143-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Phenacetin acts as a weak genotoxic compound preferentially in the kidney of DNA repair deficient Xpa mice"],"prefix":"10.1016","volume":"596","author":[{"given":"Mirjam","family":"Luijten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewoud N.","family":"Speksnijder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"van Alphen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Westerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siem H.","family":"Heisterkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"van Benthem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coen F.","family":"van Kreijl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf B.","family":"Beems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"van Steeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrfmmm.2005.12.011_bib1","first-page":"314","article-title":"Carcinoma of the renal pelvis in renal papillary necrosis","volume":"130","author":"Hultengren","year":"1965","journal-title":"Acta Chir. Scand."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00365596809135358","article-title":"Transitional cell tumors of the renal pelvis in analgesic abusers","volume":"2","author":"Bengtsson","year":"1968","journal-title":"Scand. J. Urol. Nephrol."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1445-5994.1977.tb03366.x","article-title":"Analgesic abuse, renal parenchymal disease and carcinoma of the kidney or ureter","volume":"7","author":"Mahony","year":"1977","journal-title":"Aust. N.Z. J. Med."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1464-410X.1969.tb09939.x","article-title":"Renal pelvic carcinoma in a Swedish district with abuse of a phenacetin-containing drug","volume":"41","author":"Angervall","year":"1969","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/1097-0142(197403)33:3<743::AID-CNCR2820330321>3.0.CO;2-M","article-title":"Uroepithelial tumors of the renal pelvis associated with abuse of phenacetin-containing analgesics","volume":"33","author":"Johansson","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib6","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.5694\/j.1326-5377.1970.tb84448.x","article-title":"Anaplastic transitional-cell carcinoma of the renal pelvis in association with analgesic abuse","volume":"1","author":"Adam","year":"1970","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/00365597109133599","article-title":"Renal pelvic carcinoma in phenacetin abusers","volume":"5","author":"Hoybye","year":"1971","journal-title":"Scand. J. Urol. Nephrol."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib8","first-page":"768","article-title":"Renal pelvic tumor associated with analgesic abuse","volume":"107","author":"Liu","year":"1972","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib9","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1002\/1097-0142(19820615)49:12<2617::AID-CNCR2820491235>3.0.CO;2-X","article-title":"Analgesics and cancer of the renal pelvis in New South Wales","volume":"49","author":"McCredie","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1464-410X.1983.tb06561.x","article-title":"Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women","volume":"55","author":"McCredie","year":"1983","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0022-5347(17)50936-2","article-title":"Analgesics and tobacco as risk factors for cancer of the ureter and renal pelvis","volume":"130","author":"McCredie","year":"1983","journal-title":"J. Urol."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib12","first-page":"217","article-title":"Relation of analgesic use to renal cancer: population-based findings","volume":"69","author":"McLaughlin","year":"1985","journal-title":"Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/ki.1986.154","article-title":"Phenacetin and papillary necrosis: independent risk factors for renal pelvic cancer","volume":"30","author":"McCredie","year":"1986","journal-title":"Kidney Int."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib14","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000185079","article-title":"Does paracetamol cause urothelial cancer or renal papillary necrosis?","volume":"49","author":"McCredie","year":"1988","journal-title":"Nephron"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ijc.2910440603","article-title":"The Copenhagen case-control study of renal pelvis and ureter cancer: role of analgesics","volume":"44","author":"Jensen","year":"1989","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ijc.2910530212","article-title":"Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvis","volume":"53","author":"McCredie","year":"1993","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib17","unstructured":"IARC Monographs on the evaluation of the carcinogenic risks to humans: some pharmaceutical drugs, IARC Monographs 24, 1980, pp. 135\u2013161."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib18","unstructured":"IARC Monographs on the evaluation of the carcinogenic risks to humans: overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42, IARC Monographs Suppl. 7, 1987, pp. 310\u2013312."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ijc.2910270416","article-title":"Carcinogenicity of analgesics: long-term treatment of Sprague-Dawley rats with phenacetin, phenazone, caffeine and paracetamol (acetamidophen)","volume":"27","author":"Johansson","year":"1981","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/ijc.2910290413","article-title":"Carcinogenicity of phenacetin: long-term feeding study in B6c3f1 mice","volume":"29","author":"Nakanishi","year":"1982","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/15287398509530747","article-title":"Assay of phenacetin genotoxicity using in vitro and in vivo test systems","volume":"16","author":"De Flora","year":"1985","journal-title":"J. Toxicol. Environ. Health"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jat.2550060403","article-title":"Mutagenicity testing of selected analgesics in Ames Salmonella strains","volume":"6","author":"Oldham","year":"1986","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/taap.1999.8796","article-title":"Correlation between induction of DNA fragmentation and micronuclei formation in kidney cells from rats and humans and tissue-specific carcinogenic activity","volume":"161","author":"Robbiano","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib24","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1576::AID-CNCR27>3.0.CO;2-V","article-title":"Morphologic evidence that analgesic-induced kidney pathology contributes to the progression of tumors of the renal pelvis","volume":"86","author":"Stewart","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/(SICI)1097-0215(19981023)79:5<531::AID-IJC15>3.0.CO;2-4","article-title":"Carcinomas of the renal pelvis associated with smoking and phenacetin abuse: p53 mutations and polymorphism of carcinogen-metabolizing enzymes","volume":"79","author":"Bringuier","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/377169a0","article-title":"Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA","volume":"377","author":"de Vries","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib27","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1093\/carcin\/18.12.2327","article-title":"Induction of DNA adducts and mutations in spleen, liver and lung of XPA-deficient\/lacZ transgenic mice after oral treatment with benzo[a]pyrene: correlation with tumor development","volume":"18","author":"de Vries","year":"1997","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib28","first-page":"1263","article-title":"Mice deficient in the nucleotide excision repair gene XPA have elevated sensitivity to benzo[a]pyrene induction of lung tumors","volume":"21","author":"Ide","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/carcin\/24.3.613","article-title":"Combined oral benzo[a]pyrene and inhalatory ozone exposure have no effect on lung tumor development in DNA repair-deficient Xpa mice","volume":"24","author":"Hoogervorst","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-9822(00)00002-6","article-title":"Tumor spectrum analysis in p53-mutant mice","volume":"4","author":"Jacks","year":"1994","journal-title":"Curr. Biol."},{"issue":"Suppl.","key":"10.1016\/j.mrfmmm.2005.12.011_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/019262301753178528","article-title":"Xpa and Xpa\/p53+\/\u2212 knockout mice: overview of available data","volume":"29","author":"van Kreijl","year":"2001","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/01926230490274344","article-title":"Evaluation of the Xpa-deficient transgenic mouse model for short-term carcinogenicity testing: 9-month studies with haloperidol, reserpine, phenacetin, and d-mannitol","volume":"32","author":"Lina","year":"2004","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib33","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/377657a0","article-title":"Plasmid-based transgenic mouse model for studying in vivo mutations","volume":"377","author":"Boerrigter","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/mutage\/11.1.111","article-title":"Evaluation of a plasmid-based transgenic mouse model for detecting in vivo mutations","volume":"11","author":"Doll\u00e9","year":"1996","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/mutage\/14.3.287","article-title":"Characterization of color mutants in lacZ plasmid-based transgenic mice, as detected by positive selection","volume":"14","author":"Doll\u00e9","year":"1999","journal-title":"Mutagenesis"},{"year":"1999","series-title":"S-PLUS 2000 Guide to Statistics","author":"Data Analysis Products Division","key":"10.1016\/j.mrfmmm.2005.12.011_bib36"},{"year":"1996","series-title":"BUGS: Bayesian Inference Using Gibbs Sampling, Version 0.5","author":"Spiegelhalter","key":"10.1016\/j.mrfmmm.2005.12.011_bib37"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/nar\/30.2.545","article-title":"Mutational fingerprints of aging","volume":"30","author":"Doll\u00e9","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib39","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/carcin\/22.4.619","article-title":"Intestinal toxicity and carcinogenic potential of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in DNA repair deficient XPA\u2212\/\u2212 mice","volume":"22","author":"Klein","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib40","first-page":"153","article-title":"Metabolic activation of phenacetin and phenetidine by several forms of cytochrome P-450 purified from liver microsomes of rats and hamsters","volume":"78","author":"Nohmi","year":"1987","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib41","first-page":"1038","article-title":"Study of the ability of phenacetin, acetaminophen, and aspirin to induce cytotoxicity, mutation, and morphological transformation in C3H\/10T1\/2 clone 8 mouse embryo cells","volume":"49","author":"Patierno","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib42","first-page":"3201","article-title":"Species-specific activation of phenacetin into bacterial mutagens by hamster liver enzymes and identification of N-hydroxyphenacetin O-glucuronide as a promutagen in the urine","volume":"42","author":"Camus","year":"1982","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/carcin\/3.2.167","article-title":"Mutagenicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin and their respective deacetylated metabolites in nitroreductase deficient Salmonella TA98FR and TA100FR","volume":"3","author":"Wirth","year":"1982","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib44","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/00498250412331285463","article-title":"Metabolism of human cytochrome P450 marker substrates in mouse: a strain and gender comparison","volume":"34","author":"L\u00f6fgren","year":"2004","journal-title":"Xenobiotica"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib45","series-title":"Handbook of Toxicologic Pathology","first-page":"255","article-title":"Kidney","author":"Khan","year":"2002"},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib46","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/(SICI)1098-2280(1999)34:2\/3<124::AID-EM11>3.0.CO;2-F","article-title":"Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice","volume":"34","author":"van Oostrom","year":"1999","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib47","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1158\/0008-5472.CAN-04-0350","article-title":"p53 heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice","volume":"64","author":"Hoogervorst","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrfmmm.2005.12.011_bib48","first-page":"1155","article-title":"Incidence of apoptosis, cell proliferation and P53 expression in renal cell carcinomas","volume":"17","author":"Tannapfel","year":"1997","journal-title":"Anticancer Res."}],"container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510706000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510706000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:42:50Z","timestamp":1764740570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027510706000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":48,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0027510706000029"],"URL":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2005.12.011","relation":{},"ISSN":["1386-1964"],"issn-type":[{"type":"print","value":"1386-1964"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenacetin acts as a weak genotoxic compound preferentially in the kidney of DNA repair deficient Xpa mice","name":"articletitle","label":"Article Title"},{"value":"Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2005.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}